Table 36:

All Direct Medical Costs

Age,a y	Year 1, $	Year 2, $	Year 3, $	Year 4, $	Year 5, $
Funding CGM Based on a Conservative Projection of a 20% Annual Increase
All ages	13,663,640	16,350,489	19,342,798	22,893,882	27,137,269
0–24	3,846,289	4,602,632	5,444,962	6,444,585	7,639,091
25–65	7,448,947	8,913,725	10,545,030	12,480,958	14,794,307
65+	2,368,403	2,834,131	3,352,807	3,968,338	4,703,871
Funding CGM for Entire Population With Hypoglycemia Unawareness
All ages	121,695,684	125,149,848	126,682,327	127,706,376	128,424,590
0–24	34,257,109	35,229,450	35,660,840	35,949,108	36,151,284
25–65	66,344,309	68,227,400	69,062,855	69,621,132	70,012,677
65+	21,094,266	21,692,998	21,958,632	22,136,137	22,260,629
Funding CGM for Entire Type 1 Diabetes Population
All ages	486,782,736	500,599,393	506,729,308	510,825,506	513,308,356
0–24	137,028,436	140,917,800	142,643,359	143,796,431	144,495,349
25–65	265,377,235	272,909,602	276,251,421	278,484,528	279,838,092
65+	84,377,065	86,771,991	87,834,527	88,544,547	88,974,915

Abbreviations: CGM, continuous glucose monitoring; NBI, net budget impact.

^aAges 0–24 years, full funding of blood glucose test strips (annual cost $1,243); 25–65 years, strips funded to a maximum of $920; 65+ years, full funding of strips and $170 grant for syringes and needles.